Endogenously released dopamine inhibits the binding of dopaminergic PET and SPECT ligands in superfused rat striatal slices

Synapse

Volumn 22, Issue 3, 1996, Pages 232-238

  Gifford, Andrew N ^a   Gatley, S John ^a   Ashby Jr , Charles R ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Binding; Dopamine; Electrical stimulation; PET; Slice; Striatum

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; LIGAND BINDING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BINDING, COMPETITIVE; DOPAMINE; DOPAMINE AGENTS; ELECTRIC STIMULATION; LIGANDS; MALE; NEOSTRIATUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, NEUROTRANSMITTER; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030046727     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199603)22:3<232::AID-SYN5>3.0.CO;2-D     Document Type: Article

References (56)

1. 3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmacol., 260:177-181.
2. Andersen, P.H. (1989) The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol., 166:493-504.
3. 3H-SCH 23390 binding in rat striatum. Life Sci., 37:1971-1983.
4. 2 receptors in the human neostriatum. Schiz. Bull., 14:471-484.
5. 3H-pimozide in mouse striatum: Effects of dopamine agonists and antagonists. Life Sci., 21:1163-1170.
6. 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci., 35:1885-1893.
7. 3H] spiperone binding in vivo in rat brain. J. Recept. Res. 11:163-175.
8. 125I]RTI-55: A potent ligand for dopamine transporters. Eur. J. Pharmacol., 194:133-134.
9. Butcher, S.P., Fairbrother, I.S., Kelley, J.S., and Arbuthnott, G.W. (1988) Amphetamine-induced dopamine release in the rat striatum: An in vivo microdialysis study. J. Neurochem., 50:346-355.
10. Cass, W.A., and Zahniser, N.R. (1990) Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine. Synapse, 5:336-337.
11. 50) of an enzymatic reaction. Biochem. Pharmacol., 22:3099-3108.
12. Chiodo, L.A. (1988) Dopamine-containing neurons in the mammalian central nervous system: Electrophysiology and pharmacology. Neurosci. Biobehav. Rev., 12:49-91.
13. 3H]spiperone binding: Evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J. Cereb. Blood Flow Metab., 8:291-303.
14. Creese, I., and Snyder, S.H. (1978) Behavioral and biochemical properties of the dopamine receptor. In: Psychopharmacology: A Generation of Progress. M.A. Lipton, A. DiMascio, and K.F. Killam, eds. Raven Press, New York, pp. 377-388.
15. 11C-raclopride is altered by drugs that modifv synaptic dopamine levels. Synapse. 13:350-356.
16. Dewey, S.L., Smith, G.S., Logan, J., Brodie, J.D., Simkowitz, P., MacGregor, R.R., Fowler, J .S., Volkow, N.D., and Wolf, A.P. (1993b) Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc. Natl. Acad. Sci. U.S.A., 90:11816-11820.
17. Di Chiara, G., and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A., 85:5274-5278.
18. Ellison, G., and Morris, W. (1981) Opposed stages of continuous amphetamine administration: Parallel alterations in motor stereotypes and in vivo spiroperidol accumulation. Eur J. Pharmacol., 74:207-214.
19. Farde, L., Ehrin E., Eriksson, L., Greitz, T., Hall, H., Hedstrom, C.G., Litton, J.E., and Sedvall, G. (1985) Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc. Natl Acad. Sci. U.S.A., 82:3863-3867.
20. 2 dopamine receptor binding in the living human brain by PET. Science, 231:258-261.
21. 11C]raclopride. Psychopharmacology, 92:278-284.
22. Fowler, J.S., Volkow, N.D., Wolf, A.P., Dewey, S.L., Schlyer, D.J., Macgregor, R.R., Hitzemann, R., Logan, J., Bendreim, B., Gatley, S.J., and Christman, D. (1989) Mapping cocaine binding sites in human and baboon brain in vivo. Synapse, 4:371-377.
23. 11C]methylphenidate to the dopamine transporter in vivo: Insensitivity to synaptic dopamine. Eur. J. Pharmacol. 281:141-149 (1995)
24. 11C]cocaine binding to decreases in synaptic dopamine. Synapse. 20:137-144 (1995)
25. Gerhardt, G.A., Dwoskin, L.P., and Zahniser, N.R. (1989) Outflow and overflow of picogram levels of endogenous dopamine and DOPAC from rat striatal slices: Improved methodology for studies of stimulus-evoked release and metabolism. J. Neurosci. Methods, 26:217-227.
26. 2 receptors regulating the release of dopamine and acetylocholine in the nucleus accumbens and striatum. Pharmacol. Biochem. Behav., 41:841-846.
27. 3H]acetyloeholine release by cocaine. J. Pharmacol. Exp. Ther., 263:757-761.
28. Glick, S.D., Rossman, K., Wang, S., Dong, N., and Keller, R.W., Jr. (1993) Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: Interactions with d-amphetamine. Brain Res., 628:201-208.
29. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, R.G., Luthra, S.K., Brooks, D.J., and Lammertsma, A.A. (1992) Quantitäten of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse, 12:47-54.
30. 123I]IBZM binding to the D2 receptor in nonhuman primates. Synapse, 10:177-184.
31. Innis, R.B., Seibyl, J.P., Scanley, B.E., Laruelle, M., Abi-Dargham, A., Wallace, E., Baldwin, R.M., Zea-Ponce, Y., Zoghbi, S.S., Wang, S., Guo, Y., Neumeyer, J.L., Charney, D.S., Hoffer, P.B., and Marek, K.L. (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A., 90:11965-11969.
32. Inoue, O., Tsukada, H., Yonezawa, H., Suhara, T., and Langstrom, B. (1991) Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine. Eur. J. Pharmacol., 197:143-149.
33. Kamal, L.A., Arbilla, S., and Langer, S.Z. (1981) Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: Differences between electrical stimulation, amphetamine and tyramine. J. Pharmacol. Exp. Ther., 216:592-598.
34. 2 receptors. Synapse, 15:169-176.
35. 125I]epidepride: In vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain. Life Sci., 53:241-250.
36. Kilty, J.E., Lorang, D., and Amara, S.G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science, 254:578-580.
37. 3H-raclopride: A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem. Pharmacol., 34:2251-2259.
38. Kuhar, M.J., Ritz, M.C., and Sharkey, J. (1988) Cocaine receptors on dopamine transporters mediate cocaine-reinforced behavior. In: Mechanisms of Cocaine Abuse and Toxicity C.R. Schuster and T.M. Pinkert. eds. NIDA Research Monograph 88, pp. 14-22. UA Government Printing Office, Washington, D.C.
39. 1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756. J. Nucl. Med., 35:1916-1920.
40. 2-dopamine receptor sites are separately detectable in vivo. Brain Res., 415:90-97.
41. Limberger, N., Trout, S.J., Kruk, Z.L., and Starke, K. (1991) "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: Role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol., 344:623-629.
42. 11C]raclopride binding in the brain: Model simulations and kinetic analysis of PET data. J. Cereb. Blood Flow Metab., 14:995-1010.
43. 18F]N-methylspiroperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons. Synapse, 9:195-207.
44. Maurice. T., Barbanel, G., and Vignon, J. (1993) Endogeneous dopamine differentially affects N-[1-(2-benzo(b)thiophenyl)cyclohexyl]-piperidine and cocaine binding to the dopamine uptake complex. Gen. Pharmacol., 24:191-194.
45. McDonald, W.M., Sibley, D.R., Kilpatrick, B.F., and Caron, M.G. (1984) Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D-2 dopamine receptors. Mol. Cell. Endocrinol., 36:201-209.
46. McMillen, B.A. (1983) CNS stimulants: Two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol. Sci., 4:429-432.
47. 123I]epidepride, a high affinity substituted benzamide ligand. J. Pharmacol. Exp. Ther., 252:1108-1116.
48. Reith, M.E.A., Meisler, B.E., Sershen, H., and Lajtha, A. (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol., 7:1123-1129.
49. Ross, S.B. (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J. Neurochem., 56:22-29.
50. 3H-raclopride in the mouse brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol., 340:6-12.
51. 3H-spiroperidol binding in the rat forebrain. Arch. Int. Pharmacodyn., 246:98-107.
52. 1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. U.S.A., 91:5720-5724.
53. 3) as a target for neuroleptics. Nature, 347:146-151
54. 11C]raclopride in the human brain. Synapse, 16:255-262.
55. 11C]WIN 35,428. Synapse, 15:130-142.
56. 3H]raclopride binding in the rat brain. Synapse, 9:188-194.